版本:
中国

BRIEF-Sunesis Pharmaceuticals qtrly basic and diluted loss per share $0.47

May 8 Sunesis Pharmaceuticals Inc

* Sunesis pharmaceuticals reports first quarter 2017 financial results and recent highlights

* Q1 revenue $700,000 versus $600,000

* Q1 revenue view $1.6 million -- Thomson Reuters I/B/E/S

* Sunesis pharmaceuticals inc qtrly basic and diluted loss per share of $0.47

* Q1 earnings per share view $-0.69 -- Thomson Reuters I/B/E/S

* Sunesis pharmaceuticals inc - expects that its current cash resources are sufficient to fund company into june 2018 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐